Christopher D. Byrne
Epidemiology · 2015–2024
A researcher in the Science corpus: 6 papers; trusts 15 researchers and is trusted by 2 researchers here, as inferred from the citation graph.
Subfields
- Epidemiology — 145 citations into it; #1,342 of 2,148 by trust here, #876 by citations
- Endocrinology, Diabetes and Metabolism — 92 citations into it; #360 of 623 by trust here, #301 by citations
- Hepatology — 67 citations into it; #102 of 151 by trust here, #88 by citations
- Surgery — 33 citations into it
- Molecular Biology — 31 citations into it
- Physiology — 26 citations into it
- Pathology and Forensic Medicine — 24 citations into it
- Cell Biology — 10 citations into it
Whom Christopher D. Byrne trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- G. Targher
- G. Hotamışlıgil
- Y. Sumida
- M. Talim
- B. Beutler
- V. Samuel
- Z. Younossi
- P. Tontonoz
- Q. Anstee
- A. Lonardo
Who trusts Christopher D. Byrne overall
Papers from Christopher D. Byrne's perspective
Ordered by how strongly the researchers Christopher D. Byrne trusts endorse each paper. Same corpus, a different order for every researcher.
- Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. (Gastroenterology)
- Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity (Annals medicus)
- Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity (Hepatology)
- Long‐term follow‐up of patients with NAFLD and elevated liver enzymes (Hepatology)
- The natural history of nonalcoholic fatty liver disease: a population-based cohort study. (Gastroenterology)
- EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease (Obesity Facts)
- Of markets and rights: Discourse in the 2008 and 2013 Global Action Plan for the Prevention and Control of Noncommunicable Diseases
- 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The… (Journal of the American College of Cardiology)
- Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis (Nature Reviews Gastroenterology &Hepatology)
- Association between Non-invasive Fibrosis Markers and Mortality among Adults with Non-alcoholic Fatty Liver Disease in the United States (Hepatology)
Their papers
- MASLD: a systemic metabolic disorder with cardiovascular and malignant complications (2024) — 738 citations
- Advancing the global public health agenda for NAFLD: a consensus statement (2021) — 631 citations
- The complex link between NAFLD and type 2 diabetes mellitus — mechanisms and treatments (2021) — 731 citations
- NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications (2020) — 710 citations
- Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis. (2016) — 1,217 citations
- NAFLD: a multisystem disease. (2015) — 2,771 citations